Detalles de la búsqueda
1.
Association of programmed death ligand-1 (PD-L1) expression with treatment outcomes in patients with BRAF mutation-positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenib.
Pigment Cell Melanoma Res;
31(4): 516-522, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29156488
2.
SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo.
Mol Cancer Ther;
8(12): 3181-90, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19934279
Resultados
1 -
2
de 2
1
Próxima >
>>